Liquidia (NASDAQ:LQDA) Insider Sarah Krepp Sells 276 Shares

Liquidia Corporation (NASDAQ:LQDA) insider Sarah Krepp sold 276 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $60.87, for a total transaction of $16,800.12. Following the sale, the insider owned 146,743 shares in the company, valued at $8,932,246.41. This represents a 0.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Sarah Krepp also recently made the following trade(s):

• On Monday, April 13th, Sarah Krepp sold 4,557 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total transaction of $174,852.09.

Liquidia Stock Up 0.8%

LQDA stock opened at $55.53 on Thursday. Liquidia Corporation has a 52-week low of $11.85 and a 52-week high of $63.46. The company’s 50 day simple moving average is $45.73 and its 200-day simple moving average is $39.16. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The firm has a market capitalization of $4.94 billion, a P/E ratio of 396.66 and a beta of 0.58.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. The business’s quarterly revenue was up 4187.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Liquidia Corporation will post 2.97 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on LQDA. BTIG Research upped their price objective on shares of Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Oppenheimer upped their price objective on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a research note on Thursday, March 12th. Lifesci Capital upgraded shares of Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. HC Wainwright upped their price objective on shares of Liquidia from $55.00 to $67.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Wells Fargo & Company upped their price objective on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a research note on Tuesday, May 12th. Three equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $50.88.

Institutional Trading of Liquidia

Several large investors have recently added to or reduced their stakes in the business. Covestor Ltd grew its position in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Liquidia by 7.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after buying an additional 422 shares during the period. Quantinno Capital Management LP boosted its holdings in shares of Liquidia by 3.6% during the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after buying an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Liquidia during the 4th quarter worth $25,000. Finally, ProShare Advisors LLC boosted its holdings in shares of Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after buying an additional 775 shares during the period. 64.54% of the stock is owned by institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).